Wplyw nadmiaru hormonow tarczycy na uklad sercowo-naczyniowy

• Autorzy: Noszczyk-Nowak A , Paslawska U. , Nicpon J. , Glinska K.

Warianty tytułu

EN

Influence of excessive thyroid hormones on the cardiovascular system

• Języki publikacji: PL

Abstrakty

EN

Thyroid hormones have an effect on every tissue of the organism because they carry out the functions of a catalyst of the oxidize reaction and the main regulator of metabolism. The thyroid hormones have an effect on the heart and cardiovascular system through β-receptors and they are synergistic with catecholamine. The excess and the deficiency of thyroid hormones in an organism is a cause of disorders in the cardiovascular system. These disorders are demonstrated as strong and nagging signs in animals and humans with hyperthyroidism and hypothyroidism. The disorders of heart functioning in hyperthyroidism may result in congestive heart failure (CHF). The development of heart failure in hyperthyroidism is connected with multidirectional changes in the cardiovascular system.

Słowa kluczowe

PL

fizjologia zwierzat; oddzialywanie na organizm; nadczynnosc tarczycy; hormony tarczycy; uklad sercowo-naczyniowy

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 08
• Opis fizyczny: s.887-890,bibliogr.

Twórcy

autor

Noszczyk-Nowak A

• Uniwersytet Przyrodniczy we Wroclawiu, pl.Grunwaldzki 47, 50-366 Wroclaw

autor

Paslawska U.

autor

Nicpon J.

autor

Glinska K.

Bibliografia

• 1.Allessie M., Boyden P., Camm A., Kleber A., Lab M., Legato M., Rosen M., Schwartz P., Spooner P., van Wagoner D., Waldo A.: Pathophysiology and prevention of atrial fibrillation. Circulation 2001, 103, 769-777.
• 2.Bahouth S. W.: Thyroid hormones transcriptionally regulatr the β-1 adrenergic receptor gene in cultured ventricular myocyte. J. Biol. Chem. 1991, 266, 15863-15869.
• 3.Biondi B.: Mortality in elderly patients with subclinical hyperthyroidism. Lancet 2002, 359, 799-800.
• 4.Biondi B., Fazio S., Coltroti F., Palmieri E., Carella C., Lombardi G., Sacca L.: Reentrant atrioventricular nadal tachycardia induced by levothyroxine. J. Clin. Endocrin. Metab. 1998, 83, 2643-2645.
• 5.Biondi B., Palmieri E., Lombardi G., Fazio S.: Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in regulation cardiac performance in human hyperthyroidism. J. Clin. Endocrin. Metab. 2002, 87, 968-974.
• 6.Braunwald E., Zipes D., Libby P.: Heart Disease. Saunders W. B. Co., New York 2001, 659-774, 815-889, 2151-2171.
• 7.Burggraaf J., Tulen J., Lalezari S., Schoemaker R., de Meyer P., Meinders A., Cohen A., Pijl H.: Sympathovagal imbalance in hyperthyroidism. Am. J. Physiol. Endocrinol. Metab. 2001, 281, E190-E195.
• 8.Cernohorsky J., Pelouch V., Korecky B., Vetter R.: Thyroid control of sercolemmal Na⁺/Ca⁺ exchanger and SR Ca ²⁺ - ATPase in developing rat heart. Am. J. Physiol. 1998, 275, 264-273.
• 9.Chen Y. C., Chen S. A., Chen Y. J., Chang M. S., Chan P., Lin C. I.: Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J. Am. Coll. Cardiol. 2002, 39, 366-372.
• 10.Colzani R. M., Emdin M., Conforti F., Passino C., Scarlattini M., Iervasi G.: Hyperthyroidism is associated with lengthening of ventricular repolarization. Clin. Endocrinol. 2001, 55, 27-32.
• 11.Erem C. i wsp.: Blood coagulation and fibrinolysis in patients with hyperthyroidism. J. Endocrinol. Invest. 2002, 25, 345-350.
• 12.Fenelon G., Wijns W., Andries E.: Tachycardiomyopathy: mechanisma and clinical implications. Pacing. Clin. Elactrophysiol. 1996, 19, 95-106.
• 13.Franklyn J. A., Gammage M. D.: Thyroid hormones and the heart: biology and clinical implications of hyperthyroidism and its treatment. Curr. Opin. Endocrinol. Diabetes 2000, 7, 275-300.
• 14.Foley C., McAllister R., Hasser E.: Thyroid status influences baroreflax function and autonomic contributions to arterial pressure and heart rate. Am. J. Physiol. Heart Circ. Physiol. 2001, 280, H2061-H2068.
• 15.Gajek J., Zięba I., Zyśko D.: Studies on the relationship between beta-adrenergic receptor density on cell wall lymphocytes, total serum catecholamine level and heart rate in patients with hyperthyroidism. Pol. Merkuriusz Lek. 2000, 9, 541-543.
• 16.Hammond H., White F., Buxton I., Saltzstein P., Brunton L., Longhurst J.: Increased myocardial b-receptors and adrenergic responses in hyperthyroid pigs. Am. J. Physiol. 1987, 252, H283-H290.
• 17.Hurley D., Hunter A., Hewett M., Stockigt J.: Atrial fibrillation and arterial embolism in hyperthyroidism. Aust. N. Z. Med. 1981, 11, 391-393.
• 18.Kahaly G. J., Dillmann W. H.: Thyroid hormone action in the heart. Endocrine Rev. 2005, 4, 1-47.
• 19.Kobori H., Ichihara A., Miyashita Y., Hayashi M., Saruta T.: Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J. Endocrinol. 1999, 160, 43-47.
• 20.Kobori H., Hayashi M., Saruta T.: Thyroid hormone stimulates renin gen expression throught the thyroid hormone response element. Hypertension 2001, 37, 99-110.
• 21.Komyja N., Isomoto S., Nakao K., Hayano M., Yano K.: Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. Clin. Endocrinol. 2002, 56, 39-44.
• 22.Kuncova J., Slavikova J.: Vasoactive intestinal polypeptide in rat atria: the effect of hyperthyroidism. Physiol. Res. 2000, 49, 427-434.
• 23.Noszczyk-Nowak A.: Badanie elektrofizjologiczne serca u świń w eksperymentalnej hipertyroksynemii. Medycyna Wet. (w druku).
• 24.Noszczyk-Nowak A., Pasławska U., Skrzypczak P., Nicpoń J., Gajek J., Zyśko D.: Objawy kliniczne, parametry hematologiczne i biochemiczne krwi u świń w przebiegu eksperymentalnej nadczynności tarczycy. Medycyna Wet. (w druku).
• 25.Noszczyk-Nowak A., Pasławska U., Zyśko D., Gajek J., Nicpoń J., Rabczyński J., Skrzypczak P.: Przerost mięśnia sercowego indukowany podawanie L-tyroksyny per os u rosnących świń. Medycyna Wet. 2007, 63, 113-117.
• 26.Olshausen K., Bischoff S., Kahaly G.: Cardiac arrhythmias and heart rate in hyperthyroidism. Am. J. Cardiol. 1989, 63, 930-935.
• 27.Osman F., Gammage M., Franklyn J.: Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid 2002, 12, 483-487.
• 28.Pachucki J., Burmeister L. A., Larsen P. R.: Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (NCN2) mRNA in the rat heart. Circ. Res. 1999, 85, 498-503.
• 29.Petretta M., Bonaduce D., Spinelli L., Vicario M., Nuzzo V., Marciano F., Camuso P., Sanctis V., Lupoli G.: Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur. J. Endocrinol. 2001, 145, 691-966.
• 30.Sakaguchi Y., Cui G., Sen.: Acute effects of thyroid hormone on inward rectifier potassium chanel current in guinea pig ventricular myocytes. Endocrinol. 1996, 137, 4744-4751.
• 31.Shimoni Y., Severson D. L.: Thyroid status and potassium currentsin rat ventricular myocyte. Am. J. Phisiol. 1995, 268, H 576-583.
• 32.Vos M., de Groot S., Verduyn S., van der Zande J., Leunissen H., Cleutjens J., van Bilsen M., Daemen M., Schreuder J., Allessie M., Wellens H.: Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block in related to cardiac hypertrophy and electrical remodeling. Circulation 1998, 98, 1125-1135.
• 33.Yu Y., Bilezikian J.: Tachycardia-induced cardiomiopathy secundary to thyrotoxicosis: a young man with previously unrecognized Graves' disease. Thyroid 2000, 10, 923-992.